Search
for
Sort by
Research 451–480 of 1000+
- Clinical Manifestation of Alopecia Areata After COVID-19 Infection or Vaccination
- The Ratio of Typical Clubbing in Pulled-Out Hairs as a Useful Marker in Predicting the Course of Alopecia Areata
- Efficacy of therapy with 311nm narrow-band UVB 311nm in the treatment of patients with alopecia areata associated with atopic dermatitis
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Superficial Cryotherapy Versus Intralesional Corticosteroid Injection In Alopecia Areata: A Comparative Clinical And Dermoscopic Study
- Profile of alopecia areata in patients attending dermatology out patient department in a tertiary care hospital in Gangtok, Sikkim
- Exacerbation of alopecia areata: A possible complication of sodium tetradecyl sulphate foam sclerotherapy treatment for varicose veins
- Analysis of Vitamin D Receptor (VDR) Gene Polymorphisms in Alopecia Areata
- COMPARISON OF EFFICACY OF VARIOUS TOPICAL TREATMENT MODALITIES IN ALOPECIA AREATA
- Alopecia Areata is associated with MICA and an extended HLA haplotype
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Design and development of Epigallocatechin gallate and Fenugreek seed extract loaded Nanosponge based Aloevera gel for treating Alopecia Areata
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Metabolic syndrome in Iraqi patients with Alopecia areata: A case control study
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Clinical and anamnestic features of alopecia areata in ukrainian men
- Evaluation of Serum Toll-Like Receptor 4, Interferon Gamma, and Interleukin-17 Levels in Iraqi Patients with Alopecia Areata
- Global, regional, and national burden of alopecia areata in adolescents and young adults aged 10–24 years from 1990 to 2021: a trend analysis
- Correlation of Serum Zinc and Copper Levels with Alopecia Areata
- Dermoscopic Assessment of Nail Alterations in Egyptian Patients with Alopecia Areata
- A Comparative Study to Evaluate Efficacy of Prachanna Karma Followed by Chirabilva Lepa and Gunja Lepa in the Management of Indralupta w.s.r to Alopecia Areata
- Pharmacotherapy of alopecia areata
- Tratamiento con Exosomas en Alopecia Areata Difusa Refractaria en Paciente Pediátrico: Reporte de Caso
- Risk Factors for Pediatric Alopecia Areata: Clinical and Biochemical Findings from a Case – Control Study
- Retrospective Analysis of Oral Tofacitinib Treatment for Alopecia Areata at a Tertiary Care Hospital in Saudi Arabia
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review